Inmate medication FY25

Ended Awarded Last action

Contract number
15B21725F00000003
Awardee
Awarding agency
Obligated
$804,583

Award facts

Contract value 96% obligated
$840,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Irving, TX 75039, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 $46,946
Funding Only Action P00011 $10,795
Funding Only Action P00009 $29,963
Funding Only Action P00010 -$29,963
Funding Only Action P00008 $75,560
Funding Only Action P00007 $41,282
Funding Only Action P00006 $125,000
Funding Only Action P00005 $150,000
Funding Only Action P00004 $30,000
Funding Only Action P00003 $95,000
Funding Only Action P00002 $170,000
Funding Only Action P00001 $20,000
Original award $40,000
Show all 13

About this award

McKesson Corporation, a leading pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, has been awarded a delivery order valued at $840,000 for inmate medication services through the Federal Detention Center Philadelphia. The contract, awarded on October 1, 2024, with a completion date of November 24, 2025, is structured as a Firm Fixed Price delivery order with no set-aside designation. Performance will be executed from McKesson's Irving, Texas location, and the work falls under the civilian federal agency portfolio rather than defense-related procurement. This award represents part of McKesson's ongoing role as a critical pharmaceutical supplier to the Bureau of Prisons and federal detention facilities, providing controlled and non-controlled medications essential to correctional healthcare operations.

This delivery order aligns with McKesson's established federal contract portfolio serving the Department of Justice's correctional system. The company maintains a strong track record as a prime contractor for medication procurement across multiple federal detention facilities, delivering controlled pharmaceuticals, non-controlled medications, and clinical pharmacy services. The award demonstrates continued federal confidence in McKesson's capabilities to manage complex pharmaceutical supply chains for secure facilities, consistent with the company's broader engagement across federal healthcare agencies including the Department of Veterans Affairs and the Department of Health and Human Services' Indian Health Service.

Quick answers

Who was awarded contract 15B21725F00000003?

15B21725F00000003 was awarded to Mckesson Corporation by Federal Detention Center Philadelphia (Correctional Facilities) on October 1, 2024.

How much is contract 15B21725F00000003 worth?

The government has obligated $804,583 on 15B21725F00000003. Its current value, with exercised options, is $840,000.

Is contract 15B21725F00000003 an order under another contract?

Yes. 15B21725F00000003 is a delivery order under 36W79720D0001, an indefinite delivery contract.

Was contract 15B21725F00000003 competed?

The extent of competition for 15B21725F00000003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award